Antidiabetic Drugs for Steatotic Liver Disease

Clinical trial NCT03646292 · COMPLETED

Trial details

NCT number: NCT03646292
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Type 2 Diabetes Digestive System Disease Liver Diseases Fatty Liver Metabolic Dysfunction-Associated Steatotic Liver Disease Non-Alcoholic Fatty Liver Disease Hypoglycemic Agents Physiological Effects of Drugs Sodium-Glucose Cotransporter 2 Inhibitors Pioglitazone Molecular Mechanisms of Pharmacological Action

Start date: 2018-12-06
Primary completion: 2022-06-16
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.